Want to see NRIX full AI Analyst Report?
Venetoclax, Rituximab, Obinutuzumab, Nx-5948
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B-Cell Lymphoma
Phase I/II
Recruiting
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Apr 02, 2026
―
Nx-5948
Healthy Volunteer
Phase I
Completed
Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948
Nov 01, 2024
―
Ip
Healthy Volunteers
Phase I
Completed
A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects
Sep 05, 2024
―
Nx-5948
Diffuse Large B Cell Lymphoma (Dlbcl), Marginal Zone Lymphoma (Mzl), Follicular Lymphoma (Fl), Small Lymphocytic Lymphoma (Sll), Chronic Lymphocytic Leukemia (Cll), Mantle Cell Lymphoma (Mcl), Primary Central Nervous System Lymphoma (Pcnsl), Waldenstrom Macroglobulinemia (Wm), Secondary Central Nervous System Lymphoma (Scnsl)
Phase I
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nov 12, 2021
Paclitaxel, Nx-1607
Gastroesophageal Junction (Gej) Cancer, Ovarian Cancer, Epithelial, Metastatic Urothelial Carcinoma, Metastatic Or Unresectable Melanoma, Richter Transformation, Metastatic Castration-Resistant Prostate Cancer (Mcrpc), Malignant Pleural Mesothelioma (Mpm), Triple Negative Breast Cancer (Tnbc), Non-Small Cell Lung Cancer (Nsclc), Cervical Cancer, Gastric Cancer, Head And Neck Squamous Cell Carcinoma, Diffuse Large B Cell Lymphoma (Dlbcl), Microsatellite Stable Colorectal Carcinoma
Phase I
Recruiting
A Study of NX-1607 in Adults With Advanced Malignancies
Sep 22, 2021
Nx-2127
Marginal Zone Lymphoma (Mzl), Follicular Lymphoma (Fl), Small Lymphocytic Lymphoma (Sll), Mantle Cell Lymphoma (Mcl), Diffuse Large B-Cell Lymphoma (Dlbcl), Chronic Lymphocytic Leukemia (Cll), Primary Central Nervous System Lymphoma (Pcnsl), Waldenstrom Macroglobulinemia (Wm)
Phase I
Recruiting
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Mar 29, 2021
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Nurix Therapeutics (NRIX) have in its pipeline
NRIX is currently developing the following drugs: Venetoclax, Rituximab, Obinutuzumab, Nx-5948, Pirtobrutinib, Nx-5948, Nx-5948. These drug candidates are in various stages of clinical development as the company works toward FDA approval.